Mehrdad ArjomandiView profile
Professor
Mehrdad Arjomandi, MD, is a Professor of Medicine at the University of California, San Francisco (UCSF), with a joint appointment at the San Francisco VA Health Care System (SFVA). He holds leadership roles as Director of the UCSF Human Exposure Laboratory, Director of the Environmental Medicine Clinic at SFVA, and Director of the SF VA Airborne Hazard Exposure Study Center of Excellence. His research focuses on environmental and occupational exposures contributing to chronic lung diseases, including COPD, asthma, and effects of pollutants like ozone and tobacco smoke. Education: BA in Molecular Biology (UCSD, 1991), MD (Stanford, 1996), Residency in Internal Medicine (UCLA, 1999), Fellowship in Pulmonary & Critical Care (UCSF, 2003). Key Research: Mechanisms of lung injury from airborne hazards, ozone-induced inflammation, and secondhand smoke effects. Studies include SPIROMICS, COPDGene, and VA cohort analyses. Recent work emphasizes cardiopulmonary outcomes in veterans exposed to airborne hazards, machine learning for COPD prognosis, and lung microbiota in COPD. He leads clinical trials evaluating bronchodilators and albuterol efficacy in exposed populations. Grants: Supported by NIH, Flight Attendant Medical Research Institute, VA, and Department of Defense. Awards: 2022 SFVA HeRO Award for clinical excellence and innovation. Labs/Teams: UCSF Human Exposure Lab, SFVA Environmental Medicine Clinic, and VA Airborne Hazard Study Center. Mentors over 30 trainees in translational and clinical research.










